BIA launched first of its kind Diversity and Inclusion report for UK biotech and life sciences
The importance of building a thriving, diverse workplace is a widely recognised priority across all industries. The first of its kind sector data analysis by the BioIndustry Association (BIA) demonstrates strong inclusivity and an overall level of diversity in talent working within the UK innovative life sciences and biotech sector. The new state of the nation report, Diversity and Inclusion in UK Biotech, also reveals significant diversity gaps across disciplines, management levels and demographic traits which require action at both a company and sector level.
Chancellor gives boost to medical innovation and life sciences industry in Spring Budget
The UK’s Chancellor, Jeremy Hunt, has announced a special higher R&D tax relief rate for the UK’s most innovative businesses in his Spring Budget today (15 March). The UK’s trade association for innovative life sciences and biotech, the UK BioIndustry Association (BIA), has warmly welcomed the announcement.
Statement on Silicon Valley Bank rescue package
Steve Bates OBE, CEO of the BIA, said on the sale of the Silicon Valley Bank UK to HSBC announced by the Bank of England, in consultation with the Prudential Regulation Authority (PRA), HM Treasury (HMT) and the Financial Conduct Authority (FCA).
Pharma looks to UK for innovation as global economic uncertainty hits fundraising
As global macroeconomic uncertainty hit fundraising across all sectors, investment in UK biotech fell from the all-time highs seen in 2021, new analysis from the UK BioIndustry Association (BIA) and data and insights company Clarivate shows. However, global pharma and investors looked to UK innovation to strengthen their product pipelines, with UK biotechs being acquired at a premium and others achieving pivotal milestones in their development.
BIA announces new appointments to the BIA Board
The BioIndustry Association (BIA) is pleased to announce the members who have been elected to its Board of Directors and will begin their work this month. BIA members elect five Board Directors, which includes four Corporate and one Other member. The Board Directors were voted for by the BIA’s membership in the weeks leading up to the AGM in October. These members will join the BIA Board from 1 January 2023, for a three-year term, adding to the considerable industry knowledge that the BIA Board can draw on.
BIA announces Bowel Cancer UK as its Charity Partnership for 2023
We are delighted to announce Bowel Cancer UK as its charity partner for 2023. Bowel cancer is the UK's second biggest cancer killer, claiming more than 16,500 lives a year, which is 45 people every day. The partnership with the BIA and its members across the UK’s life sciences ecosystem will play a pivotal role in raising awareness and knowledge which could have a significant and lasting impact on research and the understanding of this disease.
BIA Chairman appointed UK Government’s Life Sciences Investment Envoy
Dr Dan Mahony, Chair of the UK BioIndustry Association (BIA), has been appointed Life Sciences Investment Envoy by the Secretary of State for Business, Energy and Industrial Strategy. The Envoy will champion the UK life sciences sector to national and international investors to help increase investment in scaling life science companies.
Call to place medical and health research at the heart of economic plans
Ahead of the Autumn Statement, the Academy of Medical Sciences has led a call for the Chancellor to place medical and health research at the heart of plans for growth. The letter, signed by leading biomedical and health research institutions from the private and charitable sector including Pfizer, Wellcome, BioIndustry Association, Cancer Research UK and the British Heart Foundation, highlights the need to invest in research as a driver for health and wealth across the UK and globally.
UK biotechs enjoy best fundraising quarter of 2022
UK-based life sciences and biotech companies have raised £1.5 billion in equity finance in the first three quarters of the year, with investment activity accelerating in the three months leading to 31 August.
BIA celebrates breaking 500 members after Moderna enters membership
The BioIndustry Association (BIA) today has announced that its membership has passed 500 companies, as mRNA global player Moderna entered into the trade association’s membership.